Sertraline HCL Tablets
SPE2D220R0067 · DEPT OF DEFENSE
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation, with responses due 2020-08-27. AwardCast estimates what this specific solicitation will close for, before you bid.
SPE2D220R0067
solicitation
325412
NAICS
6505
PSC
Not set aside
set-aside
2020-08-27
responses due
What's being bought
Modification P00002 to invoke Option Year 1 effective June 28, 2022 through June 27, 2023. Amendment 0004 SPE2D220R0067 is issued to change the solicitation date to reflect August 27, 2020 at 3:00 PM EDT. Amendment 0003 SPE2D220R0067 is issued to incorporate updated and addeded clauses and provision
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| SR-SERVICES GMBH | $25K | 2 | 2024-09-30 |
| AMERICAN REGENT INC | $926 | n/a | 2024-09-30 |
| PFIZER INC | $2.2M | 4 | 2024-09-30 |
| ADVANCED ACCELERATOR APPLICATIONS USA INC | $1.9M | n/a | 2024-09-30 |
| FRESENIUS KABI USA, LLC | $5.4M | 4 | 2024-09-30 |
Explore the market
Comparable awards ran from $926 to $5.4M. Get AwardCast's forecast for THIS solicitation's closing price.
AwardCast forecasts what U.S. federal contracts close for, before you bid. Built on USASpending and SAM.gov. Not affiliated with the U.S. government. Technology by Chosing DEPT.